findmyKOL

Shree Kurup, MD

Enriched profile

Director, Vitreoretinal Diseases, Surgery and Ocular Immunology and Uveitis; Professor, Case Western Reserve University School of Medicine · University Hospitals Eye Institute

ORCIDNPI
Region🇺🇸 Cleveland, OH · Midwest · United StatesSpecialtyOphthalmologyFocusDiabetic Retinopathy / DME+1
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNone verifiedPayments2021–2025NIH fundingNone on fileWhy? →

Shree Kurup is Director, Vitreoretinal Diseases, Surgery and Ocular Immunology and Uveitis; Professor, Case Western Reserve University School of Medicine at University Hospitals Eye Institute. OpenAlex indexes 95 publications with 1,853 citations (h-index 21); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 31 Aug 2026

Shree Kurup, MD, is Director, Vitreoretinal Diseases, Surgery and Ocular Immunology and Uveitis at University Hospitals Eye Institute / Case Western Reserve University School of Medicine, Cleveland, OH. The public record shows 95 publications with 1,853 citations (h-index 21), centered on Diabetic Retinopathy / DME, Dry Eye / Uveitis. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 19 companies.

  • Most recent indexed publication: 2024 · Journal of clinical medicine
  • Top research focus: Diabetic Retinopathy / DME
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 19 companies

Generated from the cited public record · current as of 31 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Edema2 trialsMacular Edema2 trialsDry Eye / Uveitis1 trialUveitis1 trialCysts1 trialDiabetic Complications1 trialDiabetic Retinopathy / DME1 trial

Research focus

OpenAlex concept fingerprint
Diabetic Retinopathy / DMEDry Eye / Uveitis

Drugs & molecules

across trials, industry payments and publications
Iluviengeneric · FluocinoloneClinical trialsIndustry payments32PublicationsXiperegeneric · TriamcinoloneClinical trialsIndustry payments14PublicationsEyleageneric · AfliberceptClinical trialsIndustry payments13Publications

Works with

trial sponsors and companies reporting payments
Alimera Sciences, Inc.Clinical trialsIndustry payments23Regeneron Healthcare Solutions, Inc.Clinical trialsIndustry payments23Bausch & Lomb Americas Inc.Clinical trialsIndustry payments12

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
95publications

Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.

1,853citations

Total citations across indexed works.

21h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials
19companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Public positions

sourced statements on record

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 31 Aug 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 31 Aug 2026

19 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    87.1%
    Antineovascularisation agents80.6%
    Faricimab-svoa100%
    Part B, office-administered23 patients
    Corticosteroid2.8%
    Prednisolone Acetate100%
    Part D43 patients
  • Cancer & immunology

    9.7%
    Vascular Endothelial Growth Factor Inhibitor8.8%
    Aflibercept100%
    Part B, office-administered66 patients
    Folate Analog Metabolic Inhibitor0.6%
    Methotrexate100%
    Part D<11 patients
  • Musculoskeletal

    1.3%
    Cyclooxygenase Inhibitor0.9%
    Ketorolac Tromethamine100%
    Part D<11 patients
    Nonsteroidal Anti-inflammatory Drug0.4%
    Naproxen100%
    Part D<11 patients
3 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 31 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 31 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    asrs.org/find-a-specialist/profile/2291/Shree-K-Kurup

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asrs.org
  • Other

    uhhospitals.org/doctors/Kurup-Shree-1437103389

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhhospitals.org

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 31 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Calicut Medical College

    1993
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhhospitals.org
  • Board Certified

    Ophthalmology - American Board of Ophthalmology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhhospitals.org
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ophthalmologytimes.com

Editorial & leadership roles

journal and society appointments
  • Director

    Division of Vitreoretinal Diseases, Surgery and Ocular Immunology and Uveitis, University Hospitals Eye Institute

    2018
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhhospitals.org
  • Vice Chair

    Department of Ophthalmology, University Hospitals / Director of Retina

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org
  • Member

    scientific/curriculum committees, American Academy of Ophthalmology and NIH

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhhospitals.org
1 more role behind the reveal.Reveal →

Awards & honors

honors on the public record
1 more award behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution
  • Trained as Fellow

    National Eye Institute / NIH (Medical Retina and Ocular Immunology & Uveitis Fellowships, 2003-2005) and Johns Hopkins

    2005
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhhospitals.org
  • Professor

    Department of Ophthalmology and Visual Sciences, Case Western Reserve University School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhhospitals.org

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.